Lilly’s Mirikizumab Improves Fatigue in Patients with Crohn’s Disease in Phase 2 Trial
At one year, improvements in fatigue were sustained among those treated with mirikizumab - Three separate ...
Read more
Tag: Eli Lilly
Lilly’s tirzepatide shows positive results in trial for type 2 diabetes
Highest dose of tirzepatide reduced A1C by 2.58 percent and body weight by 11.7 kg (25.8 ...
Read more
Lilly and MiNA Therapeutics Announce saRNA Research Collaboration
Eli Lilly and Company and MiNA Therapeutics Limited, announced a global research collaboration to develop novel ...
Read more
Lilly collaborates with leading diabetes technology companies to integrate connected insulin pen solutions
With a goal of integrating data and technology to help streamline diabetes management, Eli Lilly and ...
Read more
Lilly accelerating baricitinib’s availability in India
Lilly is working with the Indian government to provide baricitinib donations in conjunction with the permission ...
Read more
Lilly and Incyte’s Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
Eli Lilly and Company and Incyte announced results from a second Phase 3 trial (BRAVE-AA1) evaluating ...
Read more
US FDA Revokes Emergency Use Authorization of Eli Lilly’s Monoclonal Antibody Bamlanivimab
U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody ...
Read moreUS FDA extend review period of the supplemental NDA for baricitinib of Eli Lilly and Incyte
Eli Lilly and Company and Incyte announced that the U.S. Food and Drug Administration (FDA) has ...
Read more
Joint FDA Advisory Committee Votes on Application for Tanezumab for the Treatment of Osteoarthritis Pain
Pfizer Inc and Eli Lilly today announced the outcome of the U.S. Food and Drug Administration ...
Read more